Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
GlobeNewswire
Unum Therapeutics Strengthens and Expands Leadership Team
June 13, 2019 -
PR Newswire
Akrevia Therapeutics Appoints Joseph Farmer as Chief Operating Officer
June 12, 2019 -
GlobeNewswire
Precision BioSciences Appoints Dario Scimeca as General Counsel
June 12, 2019 -
MobiHealthNews
Nebula Genomics, Merck KGaA’s EMD Serono partner on lung cancer pilot
June 11, 2019 -
Business Wire
Ivenix Infusion System Receives FDA 510(k) Clearance; Poised to Revolutionize the Infusion Pump Industry
June 11, 2019 -
GlobeNewswire
Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs
June 11, 2019 -
Business Wire
Darby Dental Supply Announces Partnership with CareStack®, Further Expanding Suite of Technology Solutions
June 5, 2019 -
Business Insider
Hua Medicine – Business & Pipeline Update
June 4, 2019 -
Business Wire
Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies
May 31, 2019 -
PR Newswire
Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer
May 30, 2019 -
BioSpace
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award
May 29, 2019 -
PR Newswire
Former Advertising.com and AOL Executive Joins Protenus Team
May 22, 2019 -
PR Newswire
Akrevia Therapeutics Appoints René Russo, PharmD, as Chief Executive Officer
May 22, 2019 -
PR Newswire
Protenus Named a 2019 ‘Cool Vendor’ in Healthcare Artificial Intelligence by Gartner
May 20, 2019 -
PR Newswire
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
May 20, 2019 -
PR Newswire
Akrevia Therapeutics Appoints Distinguished Research Leaders to Scientific Advisory Board
May 16, 2019 -
Business Wire
Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist
May 16, 2019 -
GlobeNewswire
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
May 15, 2019 -
PR Newswire
FDA Approves TraceLink DSCSA Pilot Submission for Network Solutions; Delivering 2023 Traceability By Leveraging Blockchain and Digital Recalls Across a Supply Network
May 14, 2019 -
PR Newswire
Baptist Health Partners with PatientPing, Enabling Real-Time Care Coordination Across Acute and Post-Acute Care Settings
May 14, 2019 -
GlobeNewswire
Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer
May 14, 2019 -
PR Newswire
Protenus Recognized as One of the Best Places to Work in Healthcare in 2019
May 14, 2019 -
Business Wire
Semma Therapeutics Announces Publication in Nature Demonstrating Advancements in Regenerative Cell Therapy for Type 1 Diabetes
May 8, 2019 -
PR Newswire
FARAPULSE Receives FDA Breakthrough Designation for its Endocardial Pulsed Field Ablation System
May 8, 2019 -
PR Newswire
LunaPBC Raises $4.6 Million to Accelerate Company Growth and Drive Health Breakthroughs
May 8, 2019 -
PR Newswire
Science2Startup Symposium Convened Close to 300 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections to Advance Scientific Innovation and Entrepreneurship
May 7, 2019 -
Verve
Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV
May 7, 2019 -
Business Wire
Devoted Health Plan steps up to provide $0 insulin to Medicare members with diabetes
May 7, 2019 -
PR Newswire
Protenus 2019 Drug Diversion Digest: 47.2 Million Doses Lost Due to Hospital Employee Theft and Misuse
May 7, 2019 -
PR Newswire
TraceLink Achieves 44% Overall Revenue Growth for Q1 2019
May 6, 2019 -
Baltimore Business Journal
Protenus raises $13 million in new funding round
May 6, 2019 -
Business Weekly
NodThera advances lead candidate and adds two big hitters to board
May 3, 2019 -
Business Wire
Beam Therapeutics Presents Data on Multiplex Base Editing for Engineered CAR-T Cells at American Society of Gene and Cell Therapy 22nd Annual Meeting
April 29, 2019 -
GlobeNewswire
Orchard Therapeutics Announces First Patient Dosed with Cryopreserved Formulation of OTL-103 Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome
April 25, 2019 -
GlobeNewswire
Acacia Pharma Announces Positive Phase 3 Barhemsys® Rescue Treatment Data To Be Presented At The Annual Congress Of Enhanced Recovery And Perioperative Medicine
April 25, 2019 -
PR Newswire
TraceLink Surpasses 2.3 Billion Serial Numbers Commissioned Worldwide
April 24, 2019 -
PR Newswire
The Arizona Hospital and Healthcare Association Announces Innovative Partnership with PatientPing to Enable Real-Time Care Coordination Across the State
April 24, 2019 -
BioSpace
ADC Therapeutics and Adagene Team Up to Develop Anti-Cancer Molecules
April 24, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in Phase I Clinical Trial of IBI318 Bispecific Antibody in China
April 23, 2019 -
GlobeNewswire
Hua Medicine Initiates First Combination Study of Dorzagliatin with SGLT-2 in the United States
April 22, 2019 -
PR Newswire
Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965
April 18, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of IBI302 for the Treatment of Wet AMD
April 17, 2019 -
GlobeNewswire
Precision BioSciences Announces Dosing of First Patient in Off-The-Shelf CAR T Cell Therapy Phase 1/2a Clinical Trial
April 17, 2019 -
Business Wire
Newly-Formed Prisma Health Selects Kyruus Solutions to Optimize Patient Access and Provider Network Management Post-Merger
April 17, 2019 -
Fierce Biotech
Nocion launches with $27M and ‘charged drugs’ to selectively target pain
April 17, 2019 -
Business Wire
Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners to Host Second Annual Science2Startup Symposium
April 12, 2019 -
PR Newswire
PatientPing Transforms Care for High-Risk, High-Utilizing Patients Across North Carolina through its Care Coordination Platform
April 11, 2019 -
PR Newswire
Embark Digs Up $10M Bones To End Preventable Disease In Dogs
April 11, 2019 -
Business Wire
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
April 10, 2019 -
PR Newswire
ABK Biomedical Raises $30M in Series B Financing
April 8, 2019 -
Daily Excelsior
Caplin Point subsidiary inks pact with Baxter Healthcare for generic injectable portfolio
April 8, 2019 -
GlobeNewswire
Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting
April 2, 2019 -
PR Newswire
Protenus is Top-Performing Solution in KLAS Patient Privacy Monitoring Report
April 2, 2019 -
GlobeNewswire
Precision BioSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 1, 2019 -
GlobeNewswire
Adaptimmune Presents Preclinical Data for its Next Generation SPEAR T-cell Targeting MAGE-A4 at the American Association for Cancer Research (AACR) Annual Meeting
April 1, 2019 -
GlobeNewswire
Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer
April 1, 2019 -
Xconomy
Precision Bio’s IPO Raises $126M for Pipeline of Gene-Edited Drugs
March 28, 2019 -
Labiotech
Orchard Therapeutic’s Gene Therapy Exceeds Expectations in Treating Children’s Neurological Disease
March 28, 2019 -
PR Newswire
Lewis And Clark Information Exchange Announces Partnership with PatientPing to Advance Care Coordination Efforts Across the Midwest
March 27, 2019 -
PR Newswire
Innovent Receives 10th Anniversary CHIC IPO of the Year Award
March 27, 2019 -
GlobeNewswire
Ultragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children
March 26, 2019 -
The Harvard Gazette
Harvard’s immune-silent stem cell technique licensed to Sana Biotechnology
March 26, 2019 -
PR Newswire
Akrevia Therapeutics Licenses Exclusive Rights from City of Hope to Expand Development Pipeline of Potent, Tumor Targeted Immunotherapies
March 26, 2019 -
Nasdaq
Menlo Therapeutics Announces Publication of Serlopitant Phase 2 Data for the Treatment of Pruritus Associated with Prurigo Nodularis
March 25, 2019 -
PR Newswire
Iowa Health Information Network and PatientPing Partner to Power Real-Time Care Coordination Solution
March 21, 2019 -
PR Newswire
Notable Health Onboards Resurgens Orthopaedics Physicians Onto Its Artificial Intelligence Wearable Technology Platform After Successful Pilot
March 20, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
March 20, 2019 -
Nasdaq
Coherus BioSciences Announces New Employment Inducement Grants
March 19, 2019 -
Nasdaq
Early stage cancer biotech Precision BioSciences sets terms for $126 million IPO
March 18, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.
March 18, 2019 -
GlobeNewswire
Coherus BioSciences Receives Transitional Pass-Through Status from CMS
March 18, 2019 -
GlobeNewswire
Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Office
March 18, 2019 -
PR Newswire
Artemis Health Raises $25 Million Series C Led by Bessemer Venture Partners
March 14, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Acceptance of OTL-200 Abstract for MLD at the 45th Annual Meeting of the European Society for Blood and Bone Marrow Transplantation (EBMT)
March 11, 2019 -
PR Newswire
TraceLink Submits an Interoperable Blockchain Network Solution for FDA DSCSA Pilot Project Program
March 11, 2019 -
Business Wire
Valor Performance Welcomes 12 Elite Athletes to Business Coaching Team
March 8, 2019 -
GlobeNewswire
Owkin Closes A New Venture Round Led By F-Prime Capital And Eight Roads Ventures; Appoints Health Tech Veteran Parker Moss As Chief Business Officer
March 7, 2019 -
PR Newswire
Next Generation ACO Providers on PatientPing’s Network Achieve More than $100 Million in Shared Savings
March 7, 2019 -
Business Wire
Beam Therapeutics Secures $135 Million in Series B Financing to Advance Base Editing Platform and Expand Pipeline of Precision Genetic Medicines
March 6, 2019 -
PR Newswire
TraceLink Announces Smart Inventory Tracker, an End-to-End Warehouse Compliance Solution Built on its Integrated Digital Supply Network Platform
March 5, 2019 -
PR Newswire
Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation
March 4, 2019 -
Marketplace
Precision BioSciences on deck for IPO
March 2, 2019 -
GlobeNewswire
Hua Medicine completes patient enrollment for Phase III monotherapy trial of dorzagliatin
March 1, 2019 -
Fierce Biotech
Denali expands antibody discovery deal with AbCellera
February 28, 2019 -
Business Wire
Nebula Genomics Recognizes World Rare Disease Day With Advocacy Collaborations, Opens Platform to Rare Disease Patients, Researchers
February 28, 2019 -
Drug Development Technology
Innovent begins Tyvyt dosing in liver cancer patients
February 28, 2019 -
PR Newswire
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards
February 27, 2019 -
PR Newswire
Centivo Rounds Out Leadership Team to Prepare for Expansion
February 27, 2019 -
PR Newswire
TraceLink Achieves 59% Overall Revenue Growth for Q4 2018
February 26, 2019 -
GlobeNewswire
Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD
February 25, 2019
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.